NATIONAL HARBOR, Md.—New-onset dipstick proteinuria may be a useful biomarker for predicting development of acute kidney injury (AKI) in critically ill septic patients, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.
NATIONAL HARBOR, Md.—In a recently completed clinical trial, treatment with ferumoxytol resulted in a greater hemoglobin (Hb) response than iron sucrose in hemodialysis (HD) patients with anemia and non-dialysis patients with severe anemia, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.
NATIONAL HARBOR, Md.—Hemodialysis (HD) patients receiving either epoetin or peginesatide who achieve low hemoglobin (Hb) levels have an increased rate of cardiovascular (CV) events, according to new data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.
Please login or register first to view this content.
